‘This is going to be huge’

INC. THIS MORNING ‘This is going to be huge’ Good morning, Prior to Covid-19, you may not have been familiar with mRNA vaccines, such as those made by Pfizer-BioNTech and Moderna. Those work by telling your cells to create proteins that teach your immune system how to fight the coronavirus. But mRNA therapies could be used to treat other illnesses--and a new crop of entrepreneurs have set out to further the innovation.  That’s the case for Tasuku Katada and Jacob Becraft, MIT PhD graduates and co-founders of Cambridge, Massachusetts-based mRNA company Strand Therapeutics. With a fresh infusion of $52 million, Strand aims to bring to market its method for using mRNA as a platform for developing drug cures for a range of diseases, from the rare to the neurological, starting with cancer. “This is going to be huge,” Becraft says, because the therapy has the potential to change how people think about drugs--one tiny piece of mRNA could solve a variety of problems. Check out the full story for how one company plans to ride the mRNA revolution.  SPONSORED CONTENT The bottom line: Employee health improves your bottom line. Working with Cigna helps turn health care from a cost to an investment. Our data-driven insights can help your employees and business grow. Watch Video. Inc. Best Workplaces: Applications Now Open! Awarding excellence in company culture. Apply now to be recognized as a company people love to work for. Early-rate deadline: December 10, 2021. HERE'S WHAT ELSE I'M READING TODAY: For privileged knowledge workers at least, home, life, and vacation are basically going to become just one big blob. --Inc. Developing your people is one of your most important jobs as a manager. Here's how to do it. --Inc. The best time to get credit for your business is when you don’t need it. --Inc.  Supply chain issues are hitting small retailers everywhere. Some are resorting to hoarding. --NYT Preparing for the Biden administration’s vaccine mandate, some business owners say efforts to comply are exacerbating hiring problems and stoking tensions among workers. --WSJ  ONE MORE THING: Entrepreneurs who accept that ambiguity is part of the journey are one step ahead of the game. --Inc. --Brit Morse Assistant editor, Inc. How are we doing? Send me ideas and feedback at BMorse@inc.com and on Twitter at @britnmorse. Join the visionaries who choose Inc. as their trusted source for the most accurate reporting on business. Join Inc. Unlimited today. Click here to forward to a friend. This email was sent by: Mansueto Ventures 7 World Trade Center, 29th Floor New York, NY, 10007, Unsubscribe • Update Profile • View in Browser • Privacy Policy